Resumption of Enfortumab Vedotin Supported by Diagnosis of a Late- Onset Immune-Related…
- Resource Type
- Journal
- Language
- Japanese
- Region
- Japan
- Price
- $68.00
- Article Title
- Resumption of Enfortumab Vedotin Supported by Diagnosis of a Late- Onset Immune-Related Adverse Event in Metastatic Urothelial Carcinoma
- Publication
- Acta Urologica Japonica/泌尿器科紀要
- ISSN
- 0018-1994
- Volume
- 70
- Issue
- 6
- Year
- 2024
- Pages
- 161-166
- Data Format
- Subject Fields
- Urology
- Note
- Full text is usually delivered within 1-2 hours
